Oppenheimer Maintains Outperform on ESAB, Lowers Price Target to $110

Benzinga · 2d ago
Oppenheimer analyst Bryan Blair maintains ESAB (NYSE:ESAB) with a Outperform and lowers the price target from $135 to $110.